Progress in cytokine research for ARDS: A comprehensive review.

Area of Science:

• Pulmonary Medicine
• Immunology
• Critical Care

Background:

• Acute respiratory distress syndrome (ARDS) is a severe respiratory failure with high mortality, characterized by diffuse lung injury and inflammation.
• Dysregulated cytokine activity is central to ARDS development, progression, and patient outcomes.

Purpose of the Study:

• To review the current understanding of cytokine roles in ARDS pathogenesis.
• To evaluate cytokines as potential therapeutic targets for improved clinical management of ARDS.

Main Methods:

• A comprehensive analysis of recent scientific literature was performed.
• The roles of pro-inflammatory (e.g., IL-1β, IL-6, IL-8) and anti-inflammatory cytokines (e.g., IL-10, IL-22) in ARDS were explored.
• Current and emerging cytokine-targeted therapies were assessed.

Main Results:

• Pro-inflammatory cytokines drive early inflammatory responses and lung injury in ARDS.
• Anti-inflammatory cytokines are involved in regulating and resolving inflammation.
• Targeted therapies (e.g., IL-1, IL-6 inhibitors) show promise, especially in COVID-19-associated ARDS, but efficacy requires further validation.

Conclusions:

• Understanding cytokine regulation in ARDS can inform novel therapeutic strategies.
• Future research should investigate cytokine roles in different ARDS subtypes and stages.
• Biomarker-driven, individualized treatment approaches are needed for effective ARDS management.